Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions.
Standard
Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions. / Mautner, Viktor Felix; Kluwe, Lan; Friedrich, Reinhard; Roehl, A C; Bammert, S; Högel, J; Spöri, H; Cooper, D N; Kehrer-Sawatzki, H.
In: J MED GENET, Vol. 47, No. 9, 9, 2010, p. 623-630.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions.
AU - Mautner, Viktor Felix
AU - Kluwe, Lan
AU - Friedrich, Reinhard
AU - Roehl, A C
AU - Bammert, S
AU - Högel, J
AU - Spöri, H
AU - Cooper, D N
AU - Kehrer-Sawatzki, H
PY - 2010
Y1 - 2010
N2 - Large deletions of the NF1 gene region occur in approximately 5% of patients with neurofibromatosis type-1 (NF1) and are associated with particularly severe manifestations of the disease. However, until now, the genotype-phenotype relationship has not been comprehensively studied in patients harbouring large NF1 gene deletions of comparable extent (giving rise to haploinsufficiency of the same genes).
AB - Large deletions of the NF1 gene region occur in approximately 5% of patients with neurofibromatosis type-1 (NF1) and are associated with particularly severe manifestations of the disease. However, until now, the genotype-phenotype relationship has not been comprehensively studied in patients harbouring large NF1 gene deletions of comparable extent (giving rise to haploinsufficiency of the same genes).
M3 - SCORING: Zeitschriftenaufsatz
VL - 47
SP - 623
EP - 630
JO - J MED GENET
JF - J MED GENET
SN - 0022-2593
IS - 9
M1 - 9
ER -